FOXP3 and neoplasm: Fc-region–modified anti-CTLA-4 mAb with high antibody-dependent cell-mediated cytotoxicity (ADCC) and cellular phagocytosis (ADCP) activity selectively depleted CTLA-4+Foxp3+ Tregs and consequently expanded tumour antigen-specific CD8+ T cells.